Print this page    •   Back to Web version of article

International News
Latin American Countries Reach Agreement With Drug Companies to Receive Discounted Antiretrovirals

August 10, 2005

Officials from 11 Latin American countries on Friday reached an agreement with 26 pharmaceutical companies to secure discounts of up to 66% on antiretroviral drugs, the Inter Press Service reports. The price agreement, which initially will be in place for two years, allows the countries to provide HIV-positive residents with universal access to antiretrovirals. The countries participating in the agreement include Argentina, Chile, Bolivia, Ecuador, Brazil, Peru, Venezuela, Colombia, Mexico, Paraguay and Uruguay (Valente, Inter Press Service, 8/8). Drug companies involved in the negotiations include Abbott Laboratories, GlaxoSmithKline, Merck, Bristol-Myers Squibb, Roche and Bayer (Kaiser Daily HIV/AIDS Report, 8/5). The discounts range from 15% to 66%, depending on the medicine. The cost of antiretrovirals will be reduced by an average of 45% in Bolivia, 48% in Uruguay, 52% Ecuador, 56% in Chile and 66% in Paraguay. Approximately 1.5 million HIV-positive people live in Latin America and 385,000 of them are in need of antiretroviral treatment; however, only 275,000 HIV-positive people currently have access to treatment, according to the Pan American Health Organization (Inter Press Service, 8/8).

Back to other news for August 10, 2005


Reprinted with permission from kaisernetwork.org. You can view the entire Kaiser Daily HIV/AIDS Report, search the archives, or sign up for email delivery at www.kaisernetwork.org/dailyreports/hiv. The Kaiser Daily HIV/AIDS Report is published for kaisernetwork.org, a free service of the Kaiser Family Foundation, by The Advisory Board Company. © 2004 by The Advisory Board Company and Kaiser Family Foundation. All rights reserved.




This article was provided by Henry J. Kaiser Family Foundation. It is a part of the publication Kaiser Daily HIV/AIDS Report. You can find this article online by typing this address into your Web browser:
http://www.thebody.com/content/art9546.html

General Disclaimer: TheBody.com is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through TheBody.com should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.